R. Kirkie Maswoswe

Kirkie Maswoswe is a partner in the firm’s Public M&A / Corporate Governance practice and Technology group. Her practice focuses on mergers and acquisitions, shareholder activism defense, financial advisory representations, corporate governance, and general corporate matters. Kirkie has represented clients across a broad range of industries, including technology, life sciences, real estate, media, and consumer and retail.

Kirkie has extensive experience handling M&A matters for public and private company clients, including domestic and cross-border acquisitions and dispositions, joint ventures, take-privates, and SPAC transactions. She also advises investment banks in connection with financial advisory matters, and companies and their boards of directors in connection with corporate governance and shareholder activism matters.

Kirke’s representative experience includes:

Technology M&A

• FactSet in its $1.9 billion carve-out acquisition of CUSIP Global Services from S&P Global*
• Genesys in its:
  
  • Carve-out acquisition of the Bold360 business from LogMeIn*
  • Acquisitions of Exceed.ai and Pointillist*
• Permira in its significant investments in CommentSold, Click&Boat, and Boats Group*
• LifeLock in its $2.3 billion sale to Symantec*
• Optiv Security in its sale to KKR*
• Trader Corporation in its $1.6 billion sale to Thoma Bravo*
• Dyn in its sale to Oracle*
• Thomson Reuters in its acquisition of Integration Point*
• Genpact in its $550 million acquisition of Headstrong*

Life Sciences M&A

• LumiraDx in its $3 billion de-SPAC merger with CA Healthcare*
• Goldman Sachs as a member of the buyer consortium in its $1.6 billion acquisition of New Frontier Health*
• ImmunityBio in its $3.6 billion merger with NantKwest* 
• Synageva BioPharma in its $8.4 billion sale to Alexion Pharmaceuticals*
• Pfizer in its $17 billion acquisition of Hospira*
• Cubist Pharmaceutical in its $9.5 billion sale to Merck* 
• Pfizer in its €115 million acquisition of two meningitis vaccines from GlaxoSmithKline*
• Mylan in its acquisition of Synerx Pharma*

Real Estate M&A

• Board of Directors of Home Partners of America in the $6 billion sale of Homes Partners of America to Blackstone*
• Extended Stay in its $6.1 billion sale to Blackstone and Starwood*

Financial Advisor Representations

• J.P. Morgan as financial advisor to Flexion Therapeutics in its $630 million sale to Pacira Biosciences*
• Evercore as financial advisor to Canadian Pacific in its $29 billion merger agreement with Kansas City Southern*
• Goldman Sachs as financial advisor to Penn National in its $2 billion acquisition of theScore*
• Lazard as financial advisor to Versum Materials in its $5.8 billion merger with Merck*
• Morgan Stanley as financial advisor to El Paso in its $38 billion merger with Kinder Morgan*

Spin-Off and Other Representations

• Mondelez in its $30 billion spin-off of Kraft Foods*
• DreamWorks Animation in the formation of Oriental DreamWorks, a China-focused media joint venture, with China Media Capital and Shanghai Media Group*
• Aramex in its $265 million acquisition of MyUS*
• Special Committee of Market Basket in the $1.5 billion shareholder buyout of Market Basket*
• Marquee Brands in its acquisition of Ben Sherman and related IP assets from Oxford Industries*
• BAE Systems in its $114 million sale of Safariland to Kanders*
• Stanley in its $1.1 billion sale to CGI Group*

*Denotes experience prior to joining Goodwin

Kirkie is a member of the American Bar Association, including its Women in M&A Subcommittee.

Prior to joining Goodwin, Kirkie most recently practiced at Cravath, Swaine & Moore LLP. She was also previously an investment banker at Goldman Sachs & Co., where she advised companies in the technology sector.

While in law school, Kirkie was an editor of the Harvard Law Review.

Kirkie was named to the National Black Lawyers’ Top 100 list in 2022. She was also recognized as a New York Rising Star – Mergers & Acquisitions by Super Lawyers in 2022.